Abstract: Inducible heat shock protein (HSP)70 (HSP70-1A and HSP70-1B proteins) is a chaperone responsible for assisting proper protein folding. Following stress conditions, HSP70 is highly up-regulated to mediate cytoprotective functions. In addition, HSP70 is able to trigger innate and adaptive immune responses that promote the immune recognition of antigens and to act as a cytokine when it is released. The data in the literature are controversial with regard to expression studies in peripheral blood mononuclear cells (PBMCs). In the present study, we aimed to examine if alterations of HSP70-1A/B expression are involved in the autoimmune pathogenesis of multiple sclerosis (MS). We determined both mRNA and protein expression in PBMCs of MS patients and healthy donors (HDs). We found a baseline increased expression of the HSPA1A gene in PBMCs from MS patients compared with HDs. Gene expression findings were associated with an increased protein expression of HSP70-1A/B in T lymphocytes (CD4+ and CD8+) and monocytes from MS patients under basal conditions that may reflect the immunological activation occurring in MS patients. We also provided evidence that heat shock (HS) stimulus induced HSP70-1A/B protein expression in HDs and MS patients, and that HS-induced HSP70-1A/B protein expression in monocytes correlated with the number of T2 lesions at baseline in MS patients. However, after lipopolysaccharide inflammatory stimulus, monocytes from MS patients failed to induce HSP70-1A/B protein expression. Our data hint at altered immune responses in MS and may indicate either a state of chronic stress or increased vulnerability to physiological immune responses in MS patients. 
Introduction
Heat shock proteins (HSPs) are evolutionarily conserved chaperones that assist in the proper folding of newly synthesised proteins and are responsible for the quality control of misfolded proteins. Consequently, HSPs play an essential role in promoting cell survival following stress or harmful conditions such as heat shock, nutrient deprivation, irradiation, hypoxia, oxidative and toxic stresses, infection, and exposure to inflammatory cytokines. Under such stress conditions, inducible HSPs are highly upregulated as the result of a heat shock response to maintain cellular homeostasis and to facilitate cell survival functions (1) (2) (3) (4) (5) .
Among the HSPs, HSP70 is the most conserved and intensely studied family and includes the constitutively expressed HSC70 (HSP73) and the stress-inducible HSP70 (HSP70-1A and HSP70-1B) proteins (6) (7) (8) . HSP70 is located mainly in the cytosol.
Adverse conditions trigger HSP70 expression, which then translocates to the nucleus and activates cytoprotective functions, acting as a chaperone and anti-apoptotic mediator. In addition to intracellular cytoprotective roles, HSP70 can be released actively via exosomes to the extracellular milieu, where it acts as a danger signal that induces immune responses. Furthermore, HSP70 can participate in the uptake and cross-presentation of antigens, and this role has been employed to improve tumorspecific vaccination protocols (9) (10) . The above brief summary is far from complete, but indicates that HSP70 could be involved in chronic inflammatory and autoimmune conditions at multiple levels and by several different mechanisms.
MS is considered a prototypic T cell-mediated autoimmune disease that is characterised by inflammation, and various degrees of demyelination, damage of axons and neurons and glial scarring in the central nervous system (CNS). The currently approved therapies of MS are all immunomodulatory or immunosuppressive, and neuroprotective approaches are being examined, but not yet available to patients.
In CNS lesions in both MS patients and animals with experimental autoimmune encephalomyelitis (EAE), the prototypic animal model for MS, an up-regulation of HSP70 expression has been observed and interpreted as activation of endogenous neuroprotective mechanisms (11) (12) (13) . In contrast, Cwiklinska and co-workers (2003) detected HSP70-myelin basic protein (MBP) and HSP70-proteolipid protein (PLP) complexes in the CNS lesions of MS patients. Paradoxically, these MBP/PLP-HSP70 complexes are highly immunogenic and are able to induce specific T-cell responses in animals with EAE (13) (14) (15) .
The genes coding for HSP70 (HSPA1A and HSPA1B) are located on chromosome 6 (6p21.3) within the HLA region. Gene expression studies using microarrays have reported a down-regulation of HSPA1A expression in peripheral blood mononuclear cells (PBMCs) of MS patients compared to healthy donors (HDs) (16) (17) (18) (19) . Although histopathological studies have demonstrated an up-regulation of HSP70 in MS and EAE lesions, protein analyses of HSP70 expression in PBMCs did not reveal differences between MS patients and HDs (20) . Despite the absence of differences in HSP70 protein expression in freshly isolated PBMCs, an increased induction of HSP70 expression was observed in PBMCs of MS patients following an inflammatory or heat shock stimulus (20) . The above data from previous studies as well as the known functions of HSP70 indicate that HSP70 itself and/or other family members of this fundamental cytoprotective pathway may be involved in the autoimmune pathogenesis of MS.
Based on the above in part controversial observations, we aimed to investigate the potential role of HSP70 in MS pathogenesis by determining its gene and protein expression under different experimental conditions in a well-characterized cohort of relapse-onset MS patients and age-and gender-matched HDs.
Methods

Patients
Patients with clinically isolated syndromes (CIS) and untreated relapsing-remitting MS (RRMS) patients were included in this study. No patient had clinical exacerbations or had received corticosteroid treatment during the month prior to blood sample collection.
An age-and gender-matched control group of HDs was also included. All patients and HDs gave their informed consent, and this study was approved by the local ethics committee. Demographic and baseline clinical characteristics of the MS patients and HDs included in the study are shown in Table 1 .
Sample collection
Blood samples from MS patients and HDs were collected by standard venipuncture in and in a subgroup of cryopreserved PBMC samples (9 MS patients and 10 HDs).
Total RNA was obtained from both fresh and frozen PBMCs using an RNeasy Mini Kit (Qiagen, Germany). One microgram of RNA was retrotranscribed into cDNA using an Omniscript RT kit (Qiagen), and the gene expression levels of HSPA1A were assessed by real-time PCR relative quantification using Taqman expression assays (Applied Biosystems, CA, USA). PGK1 (phosphoglycerate-kinase 1; Applied Biosystems) was used as an endogenous control. To select the appropriate endogenous control for data normalisation, 11 endogenous genes were previously tested using the Taqman human endogenous control plate (Applied Biosystems) in four PBMC samples from both MS patients and HDs. Real-time PCR was performed in an ABI Prism 7000 thermal cycler (Applied Biosystems) according to manufacturer's instructions. The threshold cycle (C T ) value for each reaction was used to calculate the relative level of gene expression for each sample using the 2 -∆∆CT method (21) . Samples were tested in triplicate.
HSP70 protein expression
The expression of intracellular HSP70-1A/B protein was assessed in CD4+ (CD3+CD8- 
Results
HSP70 gene expression is up-regulated in the PBMCs of MS patients
We first investigated differences in HSPA1A gene expression by means of real-time PCR in fresh PBMCs from 30 MS patients and 30 HDs. As shown in Figure 1A , To evaluate whether sample cryopreservation could modify HSP70 gene expression, HSPA1A mRNA expression levels were also determined in a subgroup of previously frozen/thawed PBMCs from 9 MS patients and 10 HDs. As depicted in Figure 1B , HSPA1A expression did not significantly differ between fresh and cryopreserved PBMCs from MS patients or HDs.
Total HSP70-1A/B expression is increased in T lymphocytes and monocytes from MS patients
We next examined HSP70-1A/B protein expression in CD4+ (CD3+CD8-) and CD8+
(CD3+CD8+) T lymphocytes and in monocytes (CD14+) from non-stimulated PBMCs of 32 MS patients and 30 age-and gender-matched HDs. Flow cytometry analysis showed no differences in the cytoplasmic MFI expression between MS patients and HDs ( Fig. 2A) . Similarly, the percentage of HSP70-1A/B positive cells was comparable between groups (data not shown).
Because HSP70 translocates to the nucleus following stress conditions (22), we also analysed the total (cytoplasmic plus nuclear) cellular expression of HSP70-1A/B in a subgroup of 14 MS patients and 14 HDs. Interestingly, the PBMCs from MS patients exhibited a significant increase in total HSP70-1A/B protein expression compared to
HDs in all cell types studied (for CD4, p=0.030; for CD8, p=0.007; for CD14, p=0.003) (Fig. 2B ).
Neither HSP70-1A/B T cell nor monocyte expression was associated with baseline clinical or demographic variables of MS patients or HDs.
Induction of HSP70-1A/B protein expression following HS or inflammatory stress
To study the induction of HSP70-1A/B protein expression after stress stimulus, PBMCs from 14 MS patients and 14 HDs were challenged with a thermal (HS) or an inflammatory (LPS) stimulus, and both the cytoplasmic and total HSP70-1A/B expression levels were analysed in T lymphocytes and in monocytes. As shown in Fig.   3 , HS stress induced a total HSP70-1A/B expression in both T lymphocytes and monocytes in HDs (for CD4, p<0.001; for CD8, p=0.013; for CD14, p=0.003). HS also induced HSP70-1A/B expression in PBMCs from MS patients, and differences reached statistical significance for CD8+ T cells (p=0.021) and monocytes (p=0.001) from MS patients but not in CD4+ T cells (Fig. 3A) . In addition, we found a positive correlation between total expression of HS-induced HSP70-1A/B protein in monocytes and the number of T2 lesions at baseline in MS patients (r=0.61; p=0.034). Interestingly, monocyte activation by LPS stimulation caused an increase in total HSP70-1A/B protein expression in HDs (p<0.001) but not in MS patients (Fig. 3B ). No differences were observed when cytoplasmic HSP70-1A/B expression was analysed after either HS or LPS stimulus (data not shown).
Discussion and conclusions
Traditionally, HSP70 has been considered to be involved in homeostatic functions and cytoprotection because it participates in proper protein folding, avoidance of folding mistakes, and hence in preventing protein aggregation (23) (24) (25) . In addition, it has also been reported that HSP70 blocks multiple steps of the cellular apoptosis pathway (26) (27) (28) (29) . Its close location to the MHC class II region, which remains the genomic region most consistently associated with an increased genetic risk for MS (30) , suggested that Contrary to previous studies (14-16), HSPA1A expression was found to be upregulated in PBMCs from MS patients compared to HDs. When investigating the discrepancies across studies, it should be taken into account that in previous studies HSPA1A expression was determined with the microarray technology, and single gene validation of HSPA1A findings with more sensitive techniques, such as real-time PCR, was lacking in all cases. Differences between studies were not related to the sample storage conditions, as in the present study HSPA1A expression was comparable between fresh cells and cryopreserved samples. Other factors that could have contributed to the discrepancies may be related to the clinical characteristics of MS patients: i) In the present study patients never received immunomodulatory or immunosuppressant treatment, whereas in previous studies patients with a washout period of 1-2 months between treatment and sample collection were considered eligible for gene expression profiling; ii) In the present study, PBMCs were collected from MS patients with active disease activity that fulfilled the criteria for immunomodulatory treatment. In this regard, differences in the activation status of PBMCs may also explain the differences observed across studies.
As a next step, we analysed whether the up-regulation in HSPA1A gene expression also correlated with the protein expression levels. Cytoplasmic HSP70-1A/B protein expression levels were similar between MS patients and HDs. However, because HSP70 translocates to the nucleus following stress (22), we also determined the total 
